Use of kushta hajarul yahood in cases of cholelithiasis: A clinical study

A clinical study to evaluate the efficacy of kushta Hajarul yahood in the management of Hasat e Mararah (cholelithiasis) - NILL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091634

Enrollment

Registered

2025-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K808- Other cholelithiasis

Interventions

Intervention1: KUSHTA HAJARUL YAHOOD: 500 MG TO 1 GRAM TWICE A DAY AFTER MEALS ORALLY FOR 49 DAYS Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Cholelithiasis patients having symptoms and confirmed by USG Whole Abdomen Patients of both the sexes in between the age group of 20 to 60 years Patients with functioning gall bladder Consent of patient

Exclusion criteria

Exclusion criteria: Choledocolithiasis Ca Gallbladder Contracted gallbladder Shrinked gallbladder Thickened gallbladder Fibrosed gallbladder Mucocoele of gallbladder Pyocoele of gallbladder Obstructive Jaundice Stone size less than 15 mm Multiple stones Diabetes Mellitus Pregnancy and Lactation Mentally Retarded Patients

Design outcomes

Primary

Measure	Time frame
Discomfort in right hypochondrium Pain in right hypochondrium Nausea and vomiting Flatulent and dyspepsia Tenderness (Right upper quadrant) Referred pain to tip of right shoulderTimepoint: 0, 7th, 14th, 21st, 28th, 35th and 42nd day	—

Secondary

Measure	Time frame
USG Whole AbdomenTimepoint: 0 and 42nd day	—

Countries

India

Contacts

Public ContactProf Abdul quavi

State Unani Medical College Prayagraj

baigrakhshi12@gmail.com09415337189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026